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We report a cluster of atypical Guillain-Barré syn-
drome in 10 adults temporally related to a cluster 
of four children with acute flaccid paralysis, over a 
3-month period in South Wales, United Kingdom. 
All adult cases were male, aged between 24 and 77 
years. Seven had prominent facial diplegia at onset. 
Available electrophysiological studies showed axonal 
involvement in five adults. Seven reported various 
forms of respiratory disease before onset of neuro-
logical symptoms. The ages of children ranged from 
one to 13 years, three of the four were two years old or 
younger. Enterovirus testing is available for three chil-
dren; two had evidence of enterovirus D68 infection in 
stool or respiratory samples. We describe the clinical 
features, epidemiology and state of current investiga-
tions for these unusual clusters of illness.
The event
In January 2016, an initial cluster of five cases of 
Guillain-Barré syndrome (GBS) in adult males was 
reported to Public Health Wales by neurologists at the 
University Hospital Wales in Cardiff. Unusually for GBS 
there was: prominent bilateral facial weakness (facial 
diplegia), evidence for axonal damage on nerve con-
duction studies rather than the more typical demyeli-
nating pattern; atypical clinical onset of symptoms and 
atypical clinical progression. During the initial investi-
gations, two cases of acute flaccid paralysis (AFP) in 
children from the same areas were identified.
Background
GBS is an acute inflammatory peripheral nerve disor-
der of which the commonest type is a demyelinating, 
ascending paralysis, accounting for around 90% of 
cases. There are rarer but recognised variants, includ-
ing Miller Fisher syndrome (MFS), around 5% of GBS, 
which is typified by the triad of ophthalmoplegia, 
ataxia and areflexia; and acute motor axonal neuropa-
thy (AMAN), 5% of GBS) in which an axonal rather than 
demyelinating pattern of nerve damage is seen and 
tendon reflexes can be paradoxically brisk [1].
GBS is considered to be an autoimmune disorder trig-
gered by many recognised precipitants via molecular 
mimicry. There are multiple reports of AMAN clusters, 
most notably in Asia such as the northeast China out-
breaks where an infectious agent has been suspected 
[2]. AMAN clusters in North America and Europe are 
much less common and the clinical pattern described 
by many probable cases here defy contemporary diag-
nostic categorisation [1].
There are several known infectious triggers for GBS. 
Campylobacter spp. is the most commonly reported 
prodromal infection, and has been associated with 
clusters of the axonal variants of GBS in China [3]. 
Influenza is also a known trigger [4]. More rarely other 
infectious caused by pathogens such as hepatitis A [5], 
Mycoplasma pneumoniae [6], Acinetobacter bauman-
nii [7], cytomegalovirus [8] and Ebstein-Barr virus [9] 
have been associated with GBS and AMAN syndrome. 
Recently, hepatitis E virus has been suggested as a 
possible common trigger for GBS [10], and the emerg-
ing Zika and West Nile viruses have also been linked to 
GBS [11,12].
AFP is a clinical presentation, rather than diagnosis, 
with rapid onset of weakness of one or more limbs, 
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Figure 1
Child and adult cases by local authority, adult cluster of atypical Guillain-Barré syndrome and child cluster of acute flaccid 
paralysis, South Wales, United Kingdom, October 2015‒January 2016 (n = 14)
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sometimes associated with weakness of muscles 
involved in swallowing and respiration, and progres-
sion over days and weeks. GBS is one of the differ-
ential diagnoses for AFP [13]. Acute poliomyelitis is 
another, with AFP surveillance an important part of the 
surveillance for polio. More recently, enterovirus D-68 
(EV-D68) has been found to cause an illness present-
ing with AFP, with radiological evidence of an acute 
myelitis [14].
The population included in this paper covers the 
counties of Vale of Glamorgan, Rhondda Cynon Taff, 
Merthyr Tydfil, Caerphilly, Cardiff, Newport, Blaenau 
Gwent, Torfaen, Swansea, Bridgend, Neath Port Talbot 
and Monmouthshire. The population is 1.9 million, 
with the highest populations found in the coastal city 
areas of Cardiff (capital of Wales 354,000 inhabitants), 
Swansea (241,000) and Newport (147,000). The coun-
ties of Rhondda Cynon Taff (237,000), Merthyr Tydfil 
(59,000), Blaenau Gwent (70,000), Torfaen (91,000) 
and Caerphilly (180,000) cover a hilly area north of 
the coastal towns, with a strong industrial history but 
currently relatively high levels of socioeconomic depri-
vation [15,16]. The area is served by several hospitals 
and most provide neurology services. Cases requiring 
electrophysiology, and other specialist care are usually 
referred to the University Hospital of Wales in Cardiff.
Here we present the investigation of cases and associ-
ated results reported as at noon on 20 January 2016.
Methods
Case definition
A possible cluster case was defined as a hospitalised 
patient with either GBS or AFP, in a resident of South 
Wales, with onset of paralysis on or after 1 September 
2015. A probable case was a possible case with inves-
tigations showing an axonal neuropathy or with pre-
dominant (earlier or more severe) facial weakness or 
ophthalmoplegia, or a child (under 16 years of age) 
with AFP. Onset dates refer to the onset of paralysis.
The possible case definition was used to identify cases 
for further investigation, as both AFP and GBS are rare 
and investigations required to classify them can take 
days or weeks to complete.
Laboratory investigations
Cases were clinically investigated with neuroimaging 
i.e. magnetic resonance imaging (MRI) and computed 
tomography (CT) scans, electrophysiological studies 
(nerve conduction and electromyography), and analy-
sis of anti-ganglioside antibodies as appropriate.
Laboratory investigations included testing of stool, res-
piratory (throat and naso-pharyngeal swabs), cerebro-
spinal fluid (CSF) and serum samples for a variety of 
viral [17] and bacterial pathogens.
All respiratory samples were first screened using a 
panel of real-time reverse transcription (RT)-PCR assays 
targeting influenza A and B, respiratory syncytial virus 
(RSV)-A and -B, human metapneumovirus (hMPV), 
parainfluenza virus 1-4 and finally a duplex PCR target-
ing adenovirus and M. pneumoniae. A specific rhinovi-
rus assay targeting the 5’ untranslated region (UTR) of 
the Picornaviridae family was duplexed with the hMPV 
assay. To type EV-D68, a further specific assay was 
used on all samples positive in the EV assay as devel-
oped by the EV-D68 European study group [17].
CSF pleocytosis was defined as a white cell count 
greater than 5 cells per cubic millimetre. Whole blood 
and urine samples were screened for heavy metals and 
organophosphate exposure, the latter via a red cell 
cholinesterase test.
Epidemiological investigation
Cases were interviewed using a semi-structured 
questionnaire with open questions to assess recent 
illnesses, earlier medical history and underlying condi-
tions, as well as environmental and other exposures.
To identify the background incidence of GBS in Wales, 
we searched routinely collected hospital admission 
data in Wales with a primary diagnosis of GBS based 
on the World Health Organization (WHO) International 
Statistical Classification of Diseases and Related 
Health Problems (ICD-10) classification G61.0 [18], 
over a 10-year period between 1 January 2004 and 31 
December 2014.
Results
We identified 10 adults (eight probable, two possible 
cases) and four children (all probable cases) who met 
the case definition. Case locations are displayed in 
Figure 1; most adults lived in local authority areas to 
the north of the coastal cities in South Wales.
Figure 2
Weeks of onset of paralysis for adult and child 
cases, by case category, adult cluster of atypical 
Guillain-Barré Syndrome and child cluster of 
acute flaccid paralysis, South Wales, United 
Kingdom, October 2015‒January 2016 (n = 14)
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All adult cases were male, with a median age of 45 
years (range 24–77). The dates of onset of paralysis 
ranged from 29 October 2015 to 8 January 2016 (Figure 
2).
Eight of the 10 adult cases had a prodromal illness 
consisting of respiratory tract manifestations including 
sore throats, lower and other upper respiratory tract 
symptoms and ear infections in seven, and diarrhoeal 
illness in one.
The four child cases all presented with AFP; one had 
prominent facial and eye symptoms. They were three 
females and one male, aged between 1 and 13 years, 
with three aged 2 years or younger. Three of four had 
a respiratory infection preceding onset of AFP. They 
resided in four local authority areas (Figure 1).
The Table summarises the clinical and microbiological 
features of the adult and child cases.
Neurological findings
Of the eight probable adult cases, seven presented 
with prominent, mainly asymmetric facial weakness. 
One (Case 5) had predominantly lower limb weakness 
and an AMAN pattern on electrophysiology. In five of 
the eight cases nerve conduction studies were typical 
for AMAN or AMSAN. Case 5 was the only immunosup-
pressed individual (taking 50mg oral prednisolone per 
day); he presented with an acute asymmetric lower 
limb paralysis and electrophysiologically diagnosis 
was AMAN. Ophthalmoplegia was only a feature in 
one possible case who had a demyelinating pattern on 
electrophysiology.
The possible Cases 7 and 8 were more consistent with 
classical GBS, presenting with ascending or peripheral 
Table
Demographics, clinical and laboratory findings for cases in adult cluster of atypical Guillain-Barré syndrome and child 
cluster of acute flaccid paralysis, South Wales, United Kingdom, October 2015-January 2016 (n = 14)
Case 
no
Age 
group 
(years)
Sex Neurological diagnosis
Predominant 
facial/eye 
symptomsa
Nerve 
conduction 
studies
Case 
category
Prodromal 
illness
CSF 
pleocytosisb
Stool PCR for 
enterovirus
Respiratory 
PCR for 
enterovirus
Respiratory 
PCR 
Other 
pathogens 
detected
Adult cluster 
1 40–49 M Bifacial weakness Yes AMAN Probable RTI No ND Neg None
2 50–59 M Bifacial weakness / GBS Yes AMAN Probable RTI No Neg ND
Haemophilus 
influenzae, 
adenovirus, 
rhinovirus
3 30–39 M Bifacial weakness / GBS Yes AMSAN Probable RTI ND ND ND Rhinovirus
4 60–69 M
Bifacial 
weakness / 
Ophthalmoplegia/ 
GBS
Yes AMAN Probable RTI Yes ND Neg Influenza A
5 70+ M Asymmetric leg weakness No AMAN Probable None No ND ND Negative
6 40–49 M Bifacial weakness / ophthalmoplegia Yes ND Probable RTI ND ND ND None
7 20–29 M Hand predominant GBS No AIDP Possible RTI No Neg Neg Adenovirus
8 30–39 M GBS No AIDP Possible None No ND ND None
9 40–49 M Bifacial weakness / GBS Yes ND Probable RTI No ND NEG None
10 70+ M Bifacial weakness Yes ND Probable GI No ND ND None
Child cluster 
1 0–4 F AFP No AMAN Probable RTI Yes EV-D68 Neg None
2 0–4 M Lower limb paralysis No ND Probable RTI Yes ECHO25 Neg None
3 10–14 F GBS No AMSAN Probable RTI No EV-D68 EV-D68 None
4 0–4 F Bifacial weakness / ophthalmoplegia Yes ND Probable None No Neg ND None
AFP: acute flaccid paralysis; AMAN: acute motor axonal neuropathy; AMSAN: acute motor sensory axonal neuropathy; CSF: cerebrospinal 
fluid; ECHO 25: echovirus 25; EV: enterovirus; F: female: GBS: Guillain-Barré Syndrome; GI: gastrointestinal illness; M: male; Neg: negative; 
ND: not done; Pos: positive; RTI: respiratory tract infection.
aThese are cases where facial weakness or ophthalmoplegia were present early in the illness, or were more severe than limb weakness.
bCSF pleocytosis was defined as more than 5 white cells per cubic millimetre.
Cases of enterovirus and echovirus 25 in children are highlighted in grey.`
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weakness; both had electrophysiology consistent with 
Acute Inflammatory Demyelinating Polyneuropathy 
(AIDP).
All eight probable cases received immunoglobulin and 
seven of them had either a good or excellent response 
to it. Two cases (Cases 2 and 6) had positive titres to 
anti-GQ1b antibodies.
Three adults had spinal MRIs (Cases 10, 11 and 12), 
with no abnormalities detected; five had a cranial CT or 
MRI, with no evidence of a cause for the acute illness.
Three of the four children presented with an AFP; one 
of them with marked weakness of lower limbs only. The 
other child presented with an AFP with ophthalmople-
gia and prominent facial weakness. Two had evidence 
of signal change on cervical spine MRI in keeping with 
a transverse myelitis (Cases 1 and 2).
Microbiological and toxicological investigations
Only one adult had a CSF leucocytosis (WBC 53); this 
case did not meet the criteria for a probable case. The 
clinical picture involved a complex and progressive 
ophthalmoplegia and asymmetric facial diplegia and 
the putative diagnosis of Bickerstaff’s encephalitis 
was made. Results of PCR tests on respiratory samples 
from all 10 adult cases were positive for rhinovirus or 
adenovirus in two cases, respectively, one sample was 
positive for influenza and Haemophilus influenzae was 
identified by sputum culture in one case, which also 
tested positive for rhinovirus and adenovirus (PCR, 
included in above results). Two adults were tested for 
hepatitis B and C and one for hepatitis E; all were nega-
tive. Stool culture was performed in three of the adult 
cases and was negative in all of them.
Two children had white cells in their CSF, one was pre-
dominantly lymphocytic. Three of the four children had 
real-time RT-PCR evidence of EV in stool samples, of 
which two were typed as EV-D68 and the third had an 
echovirus 25; one child who was EV-D68-positive in 
stool also had a respiratory sample positive for EV-D68. 
One also had evidence of infection with M. pneumoniae 
by respiratory real-time RT-PCR and serology.
Biochemistry results were reported for four adult cases. 
Tests for heavy metals in whole blood confirmed no 
abnormalities in all of them. Six adults were tested for 
organophosphate exposure: one showed no abnormal-
ities and five are still awaiting results.
Environmental exposures
All 10 adult cases were interviewed. Exposures reported 
more than once included contact with dogs (4/10) and 
other pets (2/10); tattoos (4/10); smoking (2/10, of 
those 1 e-cigarettes) and clay pigeon shooting (2/10). 
Two had travelled outside the United Kingdom (UK) in 
the two months before onset of illness to Spain and 
Bulgaria, respectively. None had travelled to an area 
reported to have had cases of Zika virus. None had had 
any recent vaccinations, including seasonal influenza 
vaccine, and none reported use of illicit substances, 
significant changes in medication or use of alternative 
medicines.
The four child cases were all age-appropriately vacci-
nated and none had had recent medication changes 
or exposure to toxic household chemicals; three had 
exposure to dogs or cats, and one had household 
exposure to a smoker. None had travelled outside the 
UK in the two months before onset of illness.
Excluded case
In addition to the four cases presented above, a fur-
ther child in Wales had AFP with ophthalmoplegia and 
evidence of EV-D68 in stool samples during the same 
period, and was investigated as part of the cluster. 
However, they were excluded as they fell outside the 
area included in the initial case definition.
Hospital admissions data 2004–14
There were an average of 69 (range 49–91) admis-
sions with GBS per year, an average of six (range 0–13) 
admissions per month. Admissions showed a seasonal 
pattern with the greatest number of admissions occur-
ring in January (data not shown).
The background incidence of GBS in Europe is 1.2 to 1.9 
per 100,000 [19], which would equate to around 36 to 
58 cases per year, or three to five cases per month for 
all Wales (population 3.07 million [16]).
Discussion
The adult and child cases presented are clustered in 
both space and time, with adult cases showing pre-
dominantly the more unusual variant forms of GBS. The 
majority of adult cases showed AMAN and AMSAN i.e. 
features of the axonal variants of GBS. These variants 
are rare in Europe and the United States, where they 
account for only 5% of GBS cases. However, they are 
more common in China, Japan and Central and South 
America where they constitute 30–47% of cases [19]. 
None of our cases meet the diagnostic criteria for 
MFS [1], which has a much lower incidence than GBS 
(0.1/100,000 compared with 1.2–1.9/100,000 [19]).
This cluster of 10 adult cases over a three-month 
period would constitute a winter peak within the con-
text of population estimates and hospital episode data 
for the past decade. What is unusual, compared with 
expected winter peaks of incidence, are the clinical 
features of facial weakness and asymmetric onset, and 
electrophysiological features of axonal involvement. 
The strong male predominance (all adults were male) 
is also unusual, with the usual male:female ratio esti-
mated at 1.5:1 [19].
Both adult and child cases cluster geographically out-
side major cities, with 12 of 14 living outside the three 
main cities in the area (Cardiff, Newport and Swansea), 
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despite 48% of the population of the counties with 
cases being in these cities [16].
The child cases in our cluster are clinically different 
from the cases in the adult cluster, presenting with 
a syndrome similar to that previously reported for 
EV-D68 associated AFP, with half having radiological 
evidence of a transverse myelitis. Adult AFP cases have 
been reported coincident with a rise in EV-D68 cases 
[14], but in this series child cases predominated, with 
only nine of 59 cases aged over 21 years. Twelve chil-
dren in Colorado had a neurological illness at a median 
of seven days following a febrile infection, with EV-D68 
detected in five of 11 tested [20]. Their symptoms were 
flaccid limb weakness in 10 cases, bulbar weakness in 
six and two had facial weakness, accompanied by spi-
nal MRI changes.
There is no clear hypothesis as yet for the cause of 
the adult cluster. The temporal association of the two 
clusters could represent a coincidence, or an artefact 
due to changes in local diagnosis. Current hypothe-
ses under investigation include enterovirus infection, 
either EV-D68 or other types; gastrointestinal infec-
tions such as Campylobacter spp., hepatitis E infection 
and influenza. Variant forms of GBS have been associ-
ated with C. jejuni [3], but here there is no stool culture 
evidence of campylobacteriosis. Emerging arbovirus 
infections such as Zika and West Nile virus are unlikely 
as causes for the neurological symptoms due to the 
absence of suitable vectors in Wales and any appropri-
ate travel history. The clinical picture of cases was not 
consistent with botulism.
Descriptive epidemiology, with predominance of adult 
males and some geographic clustering, might suggest 
an environmental or behavioural exposure. However, 
no common exposure supporting this theory has been 
identified and no evidence of toxic causes has been 
found from clinical samples so far.
All but four of the cases had a preceding respiratory 
tract infection. Influenza was first reported as circu-
lating in Wales from week 1 in 2016 [21], post-dating 
the illness for these cases. Respiratory samples are 
not routinely tested for enterovirus, but retrospective 
PCR testing of respiratory samples from children (under 
16 years of age) taken from 1 December to 6 January, 
found 17 of 163 with evidence of enterovirus and five of 
17 with EV-D68.
The methods used in defining the clusters have limita-
tions, mainly in keeping with an evolving early report. 
Not all cases have undergone the same level of neuro-
imaging, electrophysiological and microbiological test-
ing, so the cases are defined mainly by their clinical 
presentation. Exposures have not yet been systemati-
cally obtained using a standardised, closed-question 
questionnaire. A further review, including more inten-
sive case finding, is being undertaken to better charac-
terise the cluster.
The child cases result either from increased recogni-
tion and diagnosis or increased true incidence of neu-
rological disease caused by infection with EV-D68. 
Neurological illness due to EV-D68 has not previously 
been described in Wales. The adult and child clus-
ters may be completely separate, but are presented 
together here because of their temporal association, 
and because EV-D68 neurological illness is a relatively 
rare diagnosis in the UK, although EV-D68 is thought 
likely to be circulating in the community [22].
Further investigations planned include serology for 
hepatitis E, influenza and other possible infection 
triggers, using stored serum and new samples to be 
taken after the intravenous immunoglobulins have left 
the patients’ serum. Further antiganglioside antibody 
testing, and human leukocyte antigen (HLA) typing are 
also planned. Surveillance for atypical GBS continues 
in Wales using a standardised reporting form and fol-
lowing case finding alerts to clinicians, and enhanced 
surveillance for enterovirus infection is also planned. 
Public Health Wales has alerted clinicians, and has 
been working with Public Health England and the 
European Centre for Disease Prevention and Control 
(ECDC) to inform other European Union countries about 
this cluster via the Early Warning and Response System 
(EWRS).
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